Dongguang Chemical (SEHK:1702) Margin Rebound To 5.9% Challenges Bearish Profitability Narrative

Dongguang Chemical (SEHK:1702) has posted its FY 2025 results with first half revenue of CNY 1.2b and basic EPS of CNY 0.12, while trailing twelve month revenue came in at CNY 2.4b with basic EPS of CNY 0.23, set against a 65.5% earnings rise and a net profit margin of 5.9% for the period. Over recent periods the company has seen revenue move from CNY 1.34b in 2024 H1 to CNY 1.24b in 2024 H2 and CNY 1.18b in 2025 H1. Basic EPS shifted from CNY 0.15 in 2024 H1 to a small loss in 2024 H2 and back to CNY 0.12 in 2025 H1, setting up a picture of recovering profitability and firmer margins that investors will be watching closely.

See our full analysis for Dongguang Chemical.

With the headline numbers on the table, the next step is to see how this mix of improving margins and shifting earnings lines up with the prevailing narratives you hear around Dongguang Chemical.

Curious how numbers become stories that shape markets? Explore Community Narratives

65.5% earnings rebound against five year slide

• Over the past five years, earnings declined on average 14.4% per year, yet over the last 12 months they grew 65.5% with net profit of CNY 140.0 million on CNY 2.38b of trailing revenue.
• Bears focus on that 14.4% annual earnings decline, and this caution is partly backed by the semi annual pattern where net income moved from CNY 90.1 million in 2024 H1 to a loss of CNY 5.5 million in 2024 H2 before returning to CNY 72.3 million in 2025 H1. However, the 65.5% earnings growth over the latest year and the return to profit challenge a simple view that the business cannot recover profitability.
  • Compared with the small 2024 H2 loss, the CNY 72.3 million profit in 2025 H1 shows that earnings can swing meaningfully within a year, which weakens the idea that past declines must continue in a straight line.
  • At the same time, trailing twelve month net income of CNY 140.0 million is still measured against a history of multi year decline, so anyone taking the bearish side will likely want to see more than a single year of 65.5% growth before changing their view.

Margins at 5.9% with softer top line

• The trailing net profit margin sits at 5.9%, up from 3.3% a year earlier, while trailing revenue eased from CNY 2.58b to CNY 2.38b over the same comparison window.
• Bulls argue that better profitability per unit of sales matters more than short term revenue softness. The move from a 3.3% margin to 5.9% supports that view even as revenue in individual halves shifted from CNY 1,337.2 million in 2024 H1 to CNY 1,238.2 million in 2024 H2 and CNY 1,180.8 million in 2025 H1, which means the bullish case is more about efficiency and cost control than top line expansion.
  • What stands out for the bullish side is that margin improvement happened while the company reported a loss in 2024 H2 and then a profit of CNY 72.3 million in 2025 H1, suggesting that when operations are on track, a mid single digit margin can still translate into meaningful profit on revenue around CNY 1.2b per half.
  • On the other hand, the revenue path across recent halves shows that stronger margins do not automatically come with revenue growth, so anyone leaning bullish needs to be comfortable that a 5.9% margin on a slightly smaller sales base still fits their expectations.

On this kind of margin and earnings swing, bulls and bears are reading the same numbers very differently, so it helps to see how both sides build their story in one place. 📊 Read the what the Community is saying about Dongguang Chemical.

P/E of 6.6x versus industry 9.3x

• The shares trade on a trailing P/E of 6.6x, below the Hong Kong chemicals industry average of 9.3x and the peer average of 12.3x, with the current price of HK$1.68 also reported at about 78.8% below a DCF fair value of HK$7.91.
• Supporters of a bullish stance point to this gap between the 6.6x P/E and both the 9.3x industry level and the DCF fair value of HK$7.91 as evidence that the market is pricing in the five year 14.4% annual earnings decline more heavily than the recent 65.5% earnings growth and the 5.9% net margin. The key question for readers is whether the latest profitability data justifies that discount.
  • Fans of the bullish argument will highlight that trailing twelve month basic EPS of CNY 0.226, combined with the low P/E, means the market is paying less per unit of recent earnings than for many peers that share similar commodity and sector risks.
  • More cautious investors might reply that the long run earnings decline history helps explain why the P/E sits at 6.6x, and that the valuation gap to the DCF fair value only becomes persuasive if the recent 65.5% earnings growth and the 5.9% margin are sustained in future reporting periods.

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Dongguang Chemical's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

Seeing both risks and rewards in the recent numbers is the whole point. Look through the figures yourself and decide how they stack up for you, then round out your view with a closer look at the company's 2 key rewards and 1 important warning sign

See What Else Is Out There

Dongguang Chemical's five year earnings decline, softer revenue trend and past semi annual loss show that its profitability story still carries meaningful uncertainty for investors.

If that choppy record leaves you wanting steadier fundamentals, compare this profile against the 289 resilient stocks with low risk scores to quickly focus on companies with more resilient risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com